ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Process Industries

Asahi Kasei Corp.

  • 1,700.00 JPY
  • +31.50
  • +1.89%
  • Japan
    Sep 21, 2018
  • Ticker
    TKS(3407)
  • Prev. close
    1,668.5
  • Market cap (JPY)
    2,340.26B
  • Market cap (USD)
    20,757.15M
  • Shares
    1,402.61M

Business Summary

Asahi Kasei Corp. is a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. It operates through the following segments: Material, Homes, Health Care, and Other Businesses. The Material segment includes fibers, textiles, chemicals, and electronics. The Homes segment includes "Long Life Home" products and offers remodeling, real estate, and urban redevelopment. It also includes construction materials. The Health Care segment includes pharmaceuticals, medical care, and acute critical care. The Other Businesses segment includes engineering, employment agency, processing and sale of Asahi Kasei products, and temporary staffing. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue2,042.21B18,426.16M
Gross Profit672,802M6,070.44M
Operating income198,475M1,790.76M
Income before tax218,333M1,969.93M
Net income170,249M1,536.09M
EBITDA311,938M2,814.50M
Diluted EPS121.931.10
Dividends Per Share340.30
Total Assets2,316.13B21,778.43M
Total liabilities1,010.92B9,505.60M
Total equity1,287.38B12,105.18M
Operating cash flow249,891M2,254.67M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 1,897.76B 1,986.40B 1,940.91B 1,882.99B 2,042.21B
Gross Profit 529,773M 564,705M 606,344M 606,826M 672,802M
Operating income 143,347M 157,933M 165,203M 159,230M 198,475M
Income before tax 163,860M 158,440M 146,389M 157,388M 218,333M
Net income 101,296M 105,652M 91,754M 115,000M 170,249M
EBITDA 238,222M 253,311M 274,835M 268,423M 311,938M
Diluted EPS 72.48 75.62 65.69 82.34 121.93
Dividends Per Share 17 19 20 24 34
Total Assets 1,915.08B 2,014.53B 2,211.72B 2,254.50B 2,316.13B
Total liabilities 989,323M 916,809M 1,154.33B 1,086.38B 1,010.92B
Total equity 912,699M 1,082.65B 1,041.90B 1,151.34B 1,287.38B
Operating cash flow 244,152M 137,597M 216,218M 168,965M 249,891M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 18,945.16M 18,081.81M 16,162.93M 17,388.81M 18,426.16M
Gross Profit 5,288.65M 5,140.38M 5,049.32M 5,603.84M 6,070.44M
Operating income 1,431.01M 1,437.63M 1,375.72M 1,470.43M 1,790.76M
Income before tax 1,635.79M 1,442.24M 1,219.05M 1,453.42M 1,969.93M
Net income 1,011.22M 961.72M 764.07M 1,061.98M 1,536.09M
EBITDA 2,378.14M 2,305.83M 2,288.68M 2,478.79M 2,814.50M
Diluted EPS 0.72 0.68 0.54 0.76 1.10
Dividends Per Share 0.16 0.17 0.16 0.22 0.30
Total Assets 18,595.80M 16,798.25M 19,678.17M 20,232.43M 21,778.43M
Total liabilities 9,606.47M 7,644.85M 10,270.29M 9,749.48M 9,505.60M
Total equity 8,862.44M 9,027.75M 9,269.99M 10,332.44M 12,105.18M
Operating cash flow 2,437.33M 1,252.51M 1,800.55M 1,560.33M 2,254.67M

Valuation Measures

Mar 2018
PER11.47
ROA7.44%
ROE13.96%
Operating margin9.71%
Profit margin8.33%

Key executives

  • President & Representative Director: Hideki Kobori
  • Director & Head-Corporate Finance: Shuichi Sakamoto
  • Senior Executive Officer, General Manager-R&D: Hideyuki Yamagishi
  • Director, Head-Legal Affairs & Compliance: Nobuyuki Kakizawa
  • Representative Director, EVP, Head-Branch, R&D: Masafumi Nakao

Shareholders

  • Capital Research & Management Co. (World Investors) (6.4%)
  • Nippon Life Insurance Co. (4.5%)
  • Capital Research & Management Co. (Global Investors) (3.5%)
  • Asset Management One Co., Ltd. (3.3%)
  • Sumitomo Mitsui Financial Group, Inc. (2.5%)
  • Nomura Asset Management Co., Ltd. (2.4%)
  • Asahi Kasei Employee Stock Ownership Plan (2.3%)
  • The Vanguard Group, Inc. (2.2%)
  • Norges Bank Investment Management (1.5%)
  • BlackRock Fund Advisors (1.5%)

Contact Details

Related Companies

  • Asahi Kasei Plastics America, Inc.
  • Asahi Kasei Corporate Venture Capital
  • Asahi Kasei Board Incentive Plan
  • Asahi Kasei Corp. /Sunvieo Elastomer Business/
  • Asahi-Schewebel Co., Ltd.
  • Asahi Tokyo Investment Trust Management Co., Ltd.
  • Asahi Kasei Europe GmbH
  • Asahi Kasei (China) Investment Co. Ltd.
  • Kyokuyo Textile (Thailand) Co. Ltd.
  • Asahi Kasei Synthetic Rubber Europe NV/SA
  • Asahi Kasei Deutschland GmbH
  • Asahi Kasei E-Materials Korea, Inc.
  • Asahi Kasei Medical Trading (Korea) Co. Ltd.
  • Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
  • Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
  • Asahi Kasei EMD Taiwan Corp.
  • Asahikasei Plastics (Hong Kong) Co. Ltd.
  • Asahi Kasei Fibers Italia SRL
  • Asahikasei Plastics (America), Inc.
  • Asahi Kasei POM (Zhangjiagang) Co. Ltd.
  • ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
  • Asahi Kasei Bioprocess Europe NV/SA
  • Asahi Kasei Medical Trading Taiwan Co. Ltd.
  • Asahi Kasei Microdevices Korea Corp.
  • Asahi Kasei Microdevices (Shanghai) Co. Ltd.
  • Asahi Kasei Fibers International (Shanghai) Co. Ltd.
  • Asahi Kasei Electronics Materials Changshu Co. Ltd.
  • Asahi Kasei Performance Chemicals Corp.
  • Asahi Chemical (HK) Ltd.
  • Asahi Kasei Microdevices Taiwan Corp.

Competitors

  • Sumitomo Chemical Co., Ltd.
  • Eternal Materials Co., Ltd.
  • Covestro AG
  • Celanese Corporation
  • Platform Specialty Products Corp.
  • Eastman Kodak Company
  • Trinseo SA
  • Fresenius Medical Care AG & Co. KGaA
  • thyssenkrupp AG
  • Green Seal Holding Ltd.
  • Suominen Yhtymae Oyj
  • Everspin Technologies, Inc.
  • Aethlon Medical, Inc.
  • Radius Health Inc
  • TiGenix NV
  • CytoSorbents Corporation
  • Cirrus Logic, Inc.
  • DMC Global Inc.
  • Electrovaya Inc.
  • Nephros, Inc.
  • Stryker Corporation
Last Updated on 21 Sep, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media